Drugs / F4/AS01B
last change May 2015 re-read 2 minutes ago

F4/AS01B

Developed for
HIV infectious disease
Investigated by
GlaxoSmithKline · International AIDS Vaccine Initiative

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01264445 Feb 2011 → Nov 2012 HIV infectious disease International AIDS Vaccine Initiative Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as F4/AS01B “heterologous prime-boost with two doses of F4/AS01E or F4/AS01B followed by Ad35-GRIN” PMID 25961283 May 2015